A pilot study on the safety and efficacy of an antithrombotic therapy during carotid artery stenting (CAS).
Phase 4
Completed
- Conditions
- Those patients who have stenosis of more than 50% of the common carotid artery or internal carotid artery (diagnosed by ultrasonography or angiography), with neurological symptoms (transient cerebral ischemic stroke or cerebral stroke), or who have stenosis of more than 80% of the common carotid artery or internal carotid artery (diagnosed by ultrasonography or angiography) even if there are no neurological symptoms.
- Registration Number
- JPRN-UMIN000002674
- Lead Sponsor
- Saitama medical university international medical center Department of Endovascular Neurosurgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1Ischemic stroke within previous 48 hr 2Presence of intraluminal thrombus 3Total occlusion of target vessel 4Intracranial aneurysm > 9 mm in diameter 5Need for more than two stents 6History of bleeding disorder 7Percutaneous or surgical intervention planned within next 30 days 8Life expectancy < 1 year 9Ostial lesion of common carotid artery 10Ostial lesion of brachiocephalic artery 11Contraindication of Pletaal 12Contraindication of Aspirin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method